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the skin.
Results: The EAG repeatability was assessed with a test-retest protocol
for 14 normal subjects. This protocol showed statistically signiﬁcant
high Intraclass Correlation Coefﬁcients between the ﬁrst and second
tests for four electrode sites overlying the joint line (p < 0.05). These
sites also showed the highest mean EAG values. In the control group, the
mean amplitude of the EAG signals was statistically larger over the
medial side than over the lateral side of the knee (0.231  0.017 mV vs.
0.126  0.042 mV for two sites over the joint line, p < 0.001), reﬂecting
joint forces that are known to be higher on the medial side (mean 
standard error). For EAG signals recorded over the total knee replace-
ment, their mean amplitude was statistically not different than zero,
reﬂecting the absence of cartilage. For signals collected over the
arthritic knees, their mean amplitude was statistically lower than in
healthy subjects (0.057  0.043 mV vs. 0.231  0.017 mV for a medial
site over the joint line, p < 0.001), reﬂecting the deterioration of
cartilage caused by osteoarthritis. In the control group, the correlation
coefﬁcients between the amplitude of the EAG at each electrode site,
and anthropometric variables such as age, weight, body mass index and
height were not statistically signiﬁcant; similarly, no signiﬁcant differ-
ences were observed between men and women for the mean EAG
values at each site. Finally, the ﬁnite element model computed electric
potential distributions with maximum potential values located over the
joint line, corresponding well to the maximum values that were
measured experimentally in the Control subjects.
Conclusions: Further analyses indicate that EAG signals arise from the
‘streaming potentials’ that can be measured directly on the surface of
the articular cartilage during compression. Cartilage degradation,
produced by a reduction in the concentration of glycosaminoglycans or
collagen content, is known to decrease the amplitude of the streaming
potentials. Therefore, electroarthrography constitutes a non-invasive
method for measuring streaming potentials and for assessing cartilage
degradation. The non-invasive nature of the EAG, its sensitivity to
cartilage degradation, as well as its low cost make this approach very
interesting for the early diagnosis of osteoarthritis and to monitor
patients during the assessment of new treatments.
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EXPLORATORY ANALYSIS OF A WIDE SPECTRUM OF BIOCHEMICAL
MARKERS IN A LARGE COHORT OF INDIVIDUALS WITH SYMPTOMS
OF VERY EARLY KNEE AND HIP OSTEOARTHRITIS: DATA FROM
CHECK
W.E. van Spil, N.W. Jansen, S.C. Mastbergen, J.W. Bijlsma,
P.M. Welsing, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Firstly, to assess a wide spectrum of biochemical markers
(biomarkers) in a large cohort of individuals with symptoms of (very)
early osteoarthritis (OA), as opposed to literature mainly reporting on
small studies of individual or limited numbers of biomarkers in more
advanced OA. Secondly, to investigate interrelationships between these
biomarkers and with demographics to demonstrate validity of the
obtained dataset and extend hypotheses on the backgrounds of these
biomarkers.
Methods: Fourteen biomarkers (uCTX-II, uCTX-I, uNTX-I, sCOMP,
sPIIANP, sCS846, sC1,2C, sOC, sPINP, sHA, sPIIINP, pLeptin, pAdiponectin,
pResistin) were assessed by ELISA or RIA in CHECK (Cohort Hip & Cohort
Knee), a 10-year prospective cohort of 1002 individuals with symptoms
of early knee and/or hip OA. Associations between biomarkers and
demographics were investigated through multiple linear regression
analysis. Clusters of interrelated biomarkers within the assessed
biomarker spectrum were identiﬁed through principal component
analysis.
Results: Quality controls revealed that gathered data were technically
reliable. Principal component analysis identiﬁed six clusters, consecu-
tively designated as ‘bone-CTX-II’, ‘inﬂammation’, ‘synovium’, ‘C1,2C-
adipokines’, ‘PIIANP’, and ‘CS846’ cluster. Notably, uCTX-II clustered
with biomarkers of bone metabolism, while sCOMP clustered with
biomarkers of synovial activity. Furthermore, pResistin and pAdipo-
nectin contributed inversely to one cluster together with sC1,2C. All
biomarkers, except for sCS846, were statistically signiﬁcantly associated
with demographics.
Conclusions: This is the ﬁrst time that a wide spectrum of biomarkers
was assessed in such a large longitudinal cohort of early-OA subjects
followed in detail for 10 years. Data were generally considered of goodtechnical quality. Associations between biomarkers and demographics
were conform hypotheses based on established OA risk factors and
literature data. sCOMP was mainly associated with (markers of) syno-
vial activity. Indeed, sCOMP is (also) produced by synoviocytes, is
present in synovial tissue, and has been associated with clinical and
ultrasonographically detected signs of synovitis and/or effusion.
Furthermore, uCTX-II was mainly associated with (markers of) bone
metabolism. Other authors have also suggested this association and
uCTX-II has been linked to osteoclastic resorption of calciﬁed cartilage
by some. In summary, our unique biomarker data were considered valid
since exploratory analysis of our data extended knowledge on indi-
vidual or limited numbers of biomarkers from, mostly, smaller cohorts.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an
initiative of the Dutch Arthritis Association.
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LARGE BONE MARROW LESIONS AND WORSENING OF BONE
MARROW LESIONS IN THE MEDIAL TIBIO-FEMORAL
COMPARTMENT ARE ASSOCIATED WITH KNEES UNDERGOING
TOTAL KNEE REPLACEMENT : DATA FROM THE OSTEOARTHRITIS
INITIATIVE
F.W. Roemer 1,2, C.K. Kwoh 3, D.J. Hunter 4, B. Boudreau 3, M.J. Hannon 3,
L. Xu 1, F. Eckstein 5,6, Z. Wang 3, M.R. John 7, A. Guermazi 1. for the OAI
Investigators1Boston Univ. Sch. of Med., Boston, MA, USA; 2Klinikum
Augsburg, Augsburg, Germany; 3Univ. of Pittsburgh, Pittsburgh, PA, USA;
4Univ. of Sydney, Sydney, Australia; 5 Paracelsus Univ. Salzburg, Salzburg,
Austria; 6Chondrometrics GmbH, Ainring, Germany; 7Novartis, Basel,
Switzerland
Purpose: Total knee joint replacement (TKR) is a cost-effective proce-
dure with good long-term outcomes. However, at present there is no
clear consensus on indications for TKR. Imaging biomarkersmay be able
to aid in the decision making process on a patient level as well as in
clinical studies and trials.
Subchondral bone marrow lesions (BMLs) have been identiﬁed as
important disease features relevant not only for clinical disease mani-
festations such as pain but also for structural progression. Incidence and
increase in BMLs was found to be associated with cartilage loss. Thus,
BMLs are promising biomarkers for structural progression to important
clinical outcomes such as TKR.
The aims of this study were therefore to test whether presence and size
of BMLs were associated with increased odds of TKR, and if worsening
of BMLs over time is also associated with TKR.
Methods: We studied knees from 121 Osteoarthritis Initiative (OAI)
participants that underwent TKR before the 48 month visit for the time
point prior to TKR, i.e. “T0” (e.g. for a TKR reported at the 48 month (M)
visit, T0 ¼ 36M); and 121 control knees that did not undergo TKR that
were matched for radiographic disease stage, gender, and age within 5
years andwere assessed at the same T0 follow-up visit. MR images were
acquired at four OAI clinical centers using dedicated Siemens Trio 3 T
scanners. The coronal IW 2D TSE, the sagittal 3D DESS sequence, coronal
and axial multiplanar reformations of the 3D DESS and a sagittal IW fat
suppressed TSE sequence were used for semiquantitative assessment.
MRIs were read for subchondral BMLs in 14 articular subregions using
the semiquantitative MOAKS system, which scores BMLs in three
categories: size of BMLs, % of BML that is cystic and number of BMLs per
subregion. Only BML size, which is scored from 0-3, was considered in
the analyses.
Analyses were performed on a plate (medial tibia, medial femur, lateral
tibia, lateral femur, trochlea, patella) and compartmental level (medial
tibio-femoral joint [TFJ], lateral TFJ and patello-femoral joint - [PFJ]).
Conditional logistic regression was applied to assess if knees that
undergo TKR are more likely to have large BMLs than controls using
a per-plate analytic approach at T0. In addition, we assessed if knees
undergoing TKR have more subregions per compartment that show
BML worsening from the time point prior T0 (¼T-1) to T0.
Results: Subjects were on average 65.3 years old (SD  8.6), predomi-
nantly female (58.1%) and overweight (mean BMI 29.6 SD  4.9). In the
cross-sectional analysis, TKR knees were more likely to have large (i.e.,
grade 3) BMLs in the medial compartment when compared to matched
non-TKR knees (unadjusted OR 2.62, 95% conﬁdence interval [CI] 1.16-
5.91 for themedial tibia, and 2.35, 95% CI 1.10-5.00 for themedial femur,
respectively). In regard to the number of BMLs that exhibited increase in
size from T-1 to T0, knees with 3 subregions increasing in size in the
medial TF compartment had increased odds for TKR than knees with no
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S34subregions showing worsening (Table 1). No signiﬁcant associations
were found for the lateral TF and PF compartment and respective plates
cross-sectionally or longitudinally.
Conclusions:When compared to controls, knees that receive TKR have
increased odds of presence of large BMLs in the medial femur and/or
tibia at the time point prior TKR, while the odds for large BMLs in the
lateral TFJ or in the PFJ are not increased. Further, knees that receive TKR
have increased odds for worsening of BML size in 3 subregions in the
medial TF compartment. This work provides evidence of the clinical
predictive validity of BMLs and further justiﬁcation for their use as
outcomes in disease modifying OA trialsFigure 1. 12 Month logistic models of pain. a) ROC plot of the pain in bed model b) ROC
model of the max pain predicting model.
Figure 2. Area under the curve of the ROC of WOMAC pain predicting models with
their 95% Conﬁdence intervals.48
STRUCTURAL BIOMARKERS PREDICT ONSET OF KNEE PAIN: DATA
FROM THE OSTEOARTHRITIS INITIATIVE
J.G. Tamez-Pena 1,2, P.C. Gonzalez 2, E.H. Schreyer 2,
S.M. Totterman 2. 1 Tecnologico de Monterrey, Escuala de Med.,
Monterrey, Mexico; 2Qmetrics Technologies, Rochester, NY, USA
Purpose: Joint pain is the most signiﬁcant symptom of OA. However,
morphologic changes in bones and cartilage may precede onset of pain.
The purpose of this study was to evaluate in a case-control setting
which morphological changes predict the development of different
subcategories of knee pain at 12, 24 or 36 months in the future.
Methods: Osteoarthritis initiative (OAI) data sets were mined to ﬁnd
subjects whose right knee was free of joint pain at baseline but had
a WOMAC pain score of 5 or greater at the 36 month observation. 61
Subjects from the OAI Incidence Cohort met the inclusion criteria. A
control cohort was created bymatching age, BMI, and gender of each case
subject to an incident cohort subjectwhose36monthWOMACpain scores
were zero. The 122 subjects’ 3DDESSWEMRI series [1] were analyzed for
cartilage thickness and for bone-cartilage interface curvature and signal
contrast of the entire femur and tibia (Qmetrics, Rochester, NY). Thickness
measurementswere normalizedusing a standard reference atlas. Receiver
operating characteristic curves (ROC) and the area under the curve (AUC)
of the ROC were used to assess the potential of the quantitative
measurements as predictors of the 12, 24 and 36-month WOMAC pain
scores for following sub-categories: sitting, walking, lying in bed, climbing
stairs and standing pain. Each non-zero score was considered a positive
response. The quantitative measurements that best predicted future pain
were used to build a logistic regression model of the observed pain. The
strength of model was then characterized by ROC analysis.
Results: The age, gender and BMI of the case subjects matched to
control subjects with no statistical differences between the groups. TheROC analysis identiﬁed several morphological variables (Standard
deviation of cartilage thickness, and the presence of large thin areas of
medial cartilage and in the lateral femur condyle) which weakly pre-
dicted future pain (AUC<0.62). The subcategories analysis shows that
there is strong preference to predict bed pain at 12 month (AUC<0.73).
24-month pain and 36-month pain were harder to predict based on the
baseline observations.
Using the pain predicting variables, unconditional logistic models were
used to predict the pain. Figure 1a) shows the model ROC analysis of
pain in bed at 12 month, and 1b) the 12-month max pain model ROC.
Figure 2 shows a plot of the different AUC for all models predicting
future pain. AUC at 12-month models were better than 24 or 36-month
models. Pain in bed was more predictable and walking pain was harder
to predict using the measured variables.Conclusions: Quantitative measurements of bone and cartilage
morphology can predict onset of knee pain. The predictive power of
those descriptors can be enhanced using a multivariate model of pain
with good sensitivity and speciﬁcity especially when predicting the
onset of pain within 12 months. Furthermore, these models can be
viewed as risk factors for developing chronic knee pain; therefore, they
may be helpful in the development and test of OA therapies.
References: Tamez-Pena J. et al. “Atlas based method for the automated
segmentation and quantiﬁcation of knee features: Data from the oste-
oarthritis initiative” IEEE, ISBI, pp 1484 - 1487, 2011
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INFLAMMATORY GENOMIC AND PLASMA BIOMARKERS PREDICT
PROGRESSION OF SYMPTOMATIC KNEE OA (SKOA)
M. Attur 1, A. Statnikov 2, C.F. Aliferis 2, Z. Li 2, S. Krasnokutsky 1,
J. Samuels 1, J.D. Greenberg 1, J. Patel 1, C. Oh 1, Q.A. Lu 3, R. Ramirez 3,
J. Todd 3, S.B. Abramson 1. 1NYU Hosp. for Joint Diseases, New York, NY,
USA; 2Ctr. for Hlth.Informatics and Bioinformatics, New York, NY, USA;
3 Singulex, Alameda, CA, USA
Purpose: OA is considered a local joint disease, with increasing
recognition of the involvement of cartilage, bone and synovium. We
